Epstein Secrets

al Supplies Should Be Produced In US. • Four GOP Senators Have Said They Will Not Attend Jacksonville Convention. • Florida ICU Beds Filling Up. • Tucson Mayor Says Arizona May Have To Send Patients Out Of State. • Anti-Shutdown Group Gathering Signatures In Push To Limit Whitmer's Powers. • NBC Repo

shown to be effective in clinical trials." CNN (7/7, Cohen, Bonifield, 83.16M) reports on its website that Novavax CEO/President Stanley Erck "said Novavax's vaccine could be on the market by the first quarter of next year." The Hill (7/7, Budryk, 2.98M) reports that "the award will also cover a large-

rnment To Pay $1.6B For Rush Vaccine Development. The CBS Evening NewsVi (7/7, story 3, 1:40, O'Donnell, 4.24M) reported, "Maryland biotech company Novavax is in the hunt for a coronavirus vaccine, and getting a major dose of funding from the government's Operation Warp Speed program." The New York lime

lo "is in charge of counterintelligence and cyber for the Phoenix FBI office. Just last week, a former engineer at Raytheon Missiles and Defense in Tucson was sentenced to more than three years in prison for taking sensitive military- related technology data in his company-issued computer to China. Wei

ted by more than $10 billion in U.S taxpayer dollars. The government is also supporting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behi

lo "is in charge of counterintelligence and cyber for the Phoenix FBI office. Just last week, a former engineer at Raytheon Missiles and Defense in Tucson was sentenced to more than three years in prison for taking sensitive military-related technology data in his company-issued computer to China. Wei

ed by more than $10 billion in U.S taxpayer dollars. The government is also supporting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behin